4//SEC Filing
Degnan Chris 4
Accession 0000899243-23-008288
CIK 0001563577other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:30 AM ET
Size
5.0 KB
Accession
0000899243-23-008288
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-03-13$1.96/sh+10,000$19,593→ 10,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.95 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 8:30 AM ET
- Size
- 5.0 KB